EU-WHO Data Sharing Pact Will 'Positively Benefit' Patients, Says Pharma Industry
This article was originally published in SRA
Executive Summary
A new collaboration between EU drug regulators and the World Health Organization on sharing certain non-public information on the safety, quality and efficacy of medicines that are already authorized or under review has drawn a positive response from the pharmaceutical industry1.
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.